Is USANA Health Sciences (USNA) Stock Undervalued Right Now?
Werte in diesem Artikel
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.USANA Health Sciences (USNA) is a stock many investors are watching right now. USNA is currently sporting a Zacks Rank #2 (Buy), as well as a Value grade of A. Another valuation metric that we should highlight is USNA's P/B ratio of 1.05. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total liabilities. USNA's current P/B looks attractive when compared to its industry's average P/B of 1.52. Over the past 12 months, USNA's P/B has been as high as 1.78 and as low as 0.83, with a median of 1.28.Finally, investors will want to recognize that USNA has a P/CF ratio of 9.05. This metric takes into account a company's operating cash flow and can be used to find stocks that are undervalued based on their solid cash outlook. USNA's current P/CF looks attractive when compared to its industry's average P/CF of 11.79. Over the past year, USNA's P/CF has been as high as 11.91 and as low as 7.18, with a median of 9.53.Value investors will likely look at more than just these metrics, but the above data helps show that USANA Health Sciences is likely undervalued currently. And when considering the strength of its earnings outlook, USNA sticks out as one of the market's strongest value stocks.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report USANA Health Sciences, Inc. (USNA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: USANA Health Sciences und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf USANA Health Sciences
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf USANA Health Sciences
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu USANA Health Sciences Inc.
Analysen zu USANA Health Sciences Inc.
Datum | Rating | Analyst | |
---|---|---|---|
16.04.2019 | USANA Health Sciences Buy | Tigress Financial | |
24.10.2018 | USANA Health Sciences Buy | Pivotal Research Group | |
23.04.2018 | USANA Health Sciences Hold | Pivotal Research Group | |
07.02.2018 | USANA Health Sciences Buy | Pivotal Research Group | |
25.10.2017 | USANA Health Sciences Buy | Pivotal Research Group |
Datum | Rating | Analyst | |
---|---|---|---|
16.04.2019 | USANA Health Sciences Buy | Tigress Financial | |
24.10.2018 | USANA Health Sciences Buy | Pivotal Research Group | |
07.02.2018 | USANA Health Sciences Buy | Pivotal Research Group | |
25.10.2017 | USANA Health Sciences Buy | Pivotal Research Group | |
26.07.2017 | USANA Health Sciences Buy | Pivotal Research Group |
Datum | Rating | Analyst | |
---|---|---|---|
23.04.2018 | USANA Health Sciences Hold | Pivotal Research Group | |
01.05.2017 | USANA Health Sciences Hold | Pivotal Research Group | |
06.08.2015 | USANA Health Sciences Neutral | D.A. Davidson & Co. | |
23.04.2015 | USANA Health Sciences Hold | Canaccord Adams | |
30.10.2014 | USANA Health Sciences Hold | Canaccord Adams |
Datum | Rating | Analyst | |
---|---|---|---|
29.04.2010 | USANA "underperform" | Wedbush Morgan Securities Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für USANA Health Sciences Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen